InsiderClue
← All stocks

Apogee Therapeutics, Inc.

APGE Net selling
CIK 0001974640 #925 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$174.16M
$34.80M on a plan · $5.84M straight out of an exercise
Sold at will
$133.53M
1 of 83 sales
Net
−$174.16M
−$133.53M against sales at will

By person

8 insiders · 86 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Fairmount Funds Management LLC entity
Director
—
$133.53M (1)
−$133.53M
340,855
0.4524%
$45.73M
−86.3%
HENDERSON MICHAEL THOMAS
Chief Executive Officer
—
$28.39M (33) scheduled
−$28.39M
0
0.0000%
$0.00
−100.0%
Dambkowski Carl
Chief Medical Officer
—
$10.15M (27) scheduled
−$10.15M
0
0.0000%
$0.00
−100.0%
Henderson Jane
Chief Financial Officer
—
$2.09M (22) scheduled
−$2.09M
0
0.0000%
$0.00
−100.0%
Shah Nimish P
Director
—
—
—
0
0.0000%
$0.00
−100.0%
McKenna Mark C.
Director
—
—
—
0
0.0000%
$0.00
—
JONES WILLIAM A JR
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Fox Jennifer A.
Director
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

25
Insider
Date
Role
Action
Shares
Price
Amount
Dambkowski Carl
5 Aug 2026
Chief Medical Officer
Sold after exercise
5,500
$134.17
$737.94K
Dambkowski Carl
1 Jul 2026
Chief Medical Officer
Sold after exercise
5,500
$132.74
$730.07K
Dambkowski Carl
3 Jun 2026
Chief Medical Officer
Sold after exercise
5,500
$78.71
$432.91K
Dambkowski Carl
6 May 2026
Chief Medical Officer
Sold after exercise
1,800
$84.60
$152.28K
Dambkowski Carl
6 May 2026
Chief Medical Officer
Sold after exercise
3,700
$83.92
$310.50K
Dambkowski Carl
1 Apr 2026
Chief Medical Officer
Sold after exercise
100
$85.89
$8.59K
Dambkowski Carl
1 Apr 2026
Chief Medical Officer
Sold after exercise
2,702
$85.33
$230.56K
Dambkowski Carl
1 Apr 2026
Chief Medical Officer
Sold after exercise
2,698
$84.31
$227.47K
Dambkowski Carl
4 Mar 2026
Chief Medical Officer
Sold after exercise
200
$73.26
$14.65K
Dambkowski Carl
4 Mar 2026
Chief Medical Officer
Sold after exercise
2,075
$71.98
$149.36K
Dambkowski Carl
4 Mar 2026
Chief Medical Officer
Sold after exercise
3,225
$70.33
$226.81K
Dambkowski Carl
4 Feb 2026
Chief Medical Officer
Sold after exercise
200
$68.94
$13.79K
Dambkowski Carl
4 Feb 2026
Chief Medical Officer
Sold after exercise
100
$67.88
$6.79K
Dambkowski Carl
4 Feb 2026
Chief Medical Officer
Sold after exercise
1,299
$66.85
$86.84K
Dambkowski Carl
4 Feb 2026
Chief Medical Officer
Sold after exercise
1,420
$65.83
$93.48K
Dambkowski Carl
4 Feb 2026
Chief Medical Officer
Sold after exercise
2,481
$64.88
$160.97K
Dambkowski Carl
7 Jan 2026
Chief Medical Officer
Sold after exercise
100
$80.06
$8.01K
Dambkowski Carl
7 Jan 2026
Chief Medical Officer
Sold after exercise
826
$79.04
$65.29K
Dambkowski Carl
7 Jan 2026
Chief Medical Officer
Sold after exercise
14,820
$77.90
$1.15M
Dambkowski Carl
7 Jan 2026
Chief Medical Officer
Sold after exercise
2,954
$77.13
$227.84K
Dambkowski Carl
5 Nov 2025
Chief Medical Officer
Sold after exercise
678
$56.51
$38.31K
Dambkowski Carl
5 Nov 2025
Chief Medical Officer
Sold after exercise
5,607
$55.58
$311.64K
Dambkowski Carl
5 Nov 2025
Chief Medical Officer
Sold after exercise
2,200
$54.83
$120.63K
Dambkowski Carl
5 Nov 2025
Chief Medical Officer
Sold after exercise
2,300
$53.62
$123.33K
Dambkowski Carl
1 Oct 2025
Chief Medical Officer
Sold after exercise
5,110
$39.80
$203.38K
Show all 86 transactions →

What was left out

Form 4 filings counted 58
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 57
Sales straight out of an exercise 25
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 3,727,244
History held since 17 Jul 2023